Evan Newbold

Title: The Innovations of Evan Newbold

Introduction

Evan Newbold is an accomplished inventor based in Charlottesville, VA. He has made significant contributions to the field of medicine, particularly in the treatment of movement disorders. With a total of 2 patents to his name, Newbold is recognized for his innovative approaches to addressing complex health issues.

Latest Patents

Newbold's latest patents focus on treating essential tremor using (R)-2-(4-Isopropylphenyl)-N-(1-(5-(2,2,2-Trifluoroethoxy)pyridin-2-yl)ethyl)acetamide. This invention relates to methods and materials for treating mammals that have, or are at risk of developing, movement disorders such as essential tremor, epilepsy, and Parkinson's disease. The compositions include T-type calcium channel antagonists, specifically Cav3 antagonists like CX-8998, and methods for administering these compositions to effectively treat affected mammals.

Career Highlights

Evan Newbold has established himself as a key figure in the medical research community. His work at Cavion, Inc. has allowed him to explore innovative solutions for treating debilitating conditions. His dedication to advancing medical science is evident in his patent filings and ongoing research efforts.

Collaborations

Newbold collaborates with notable colleagues, including Margaret S Lee and Spyridon Papapetropoulos. These partnerships enhance the research and development process, fostering an environment of innovation and shared expertise.

Conclusion

Evan Newbold's contributions to the field of medicine through his patents and collaborative efforts highlight his commitment to improving the lives of those affected by movement disorders. His work continues to pave the way for future advancements in treatment options.